TIP Conference: ECS Botanics’ German Advantage
TIP Conference: ECS Botanics’ German Advantage
About this video
ECS Botanics grows and manufactures medicinal cannabis in north-west Victoria and sells its own branded products to Australian patients through GPs. CEO Nan-Maree Schoerie says the company’s shift from bulk supply to its own brands now makes up more than 70% of the business and has delivered five consecutive quarters of positive operating cash flow. New European rules that require growers to also manufacture on the same site, to EU GMP standards, have cut out most of the global competition and opened up Germany as ECS’s biggest growth market.
Nan-Maree also explains a new profit-sharing deal to take ECS’s flagship brand into the UK through Curaleaf, and the patented delivery technology that makes its oils and capsules around four times more bioavailable. With a market capitalisation of around $8 million against revenue of about $21 million, she talks frankly about why the sector’s reputation has weighed on valuations, and why she’s now focused on telling the ECS story to investors.